Internal Medicine, Rheumatology · Valdosta, GA
NPI
1073695292
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2418 N Oak St
Valdosta, GA, 31602
Phone (229) 219-0247
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
183,639 services
Medicare patients, 2024
1,591
Average age 74
Drug cost, 2024
$7.6M
11,257 prescriptions
Company payments, 2025
$781
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William C Tidmore Jr. was code J0897 (injection, denosumab, 1 mg), 44,640 times for 421 patients. In total William C Tidmore Jr. billed 183,639 services in 176 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 44,640 | 421 | $20.40 | $911K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 17,650 | 18 | $8.01 | $141K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 12,810 | 12 | $8.46 | $108K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,501 | 20 | $33.58 | $353K |
| J9312 Injection, rituximab, 10 mg | Office | 7,400 | 22 | $57.89 | $428K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 4,920 | 65 | $0.10 | $469 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 4,390 | 20 | $24.71 | $108K |
| 99214 Office E&M - Established | Office | 2,362 | 1,131 | $85.59 | $202K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,038 | 1,075 | $12.33 | $25K |
| 36415 Venipuncture Blood Collection | Office | 1,942 | 952 | $8.54 | $17K |
| 96372 Injection Administration | Office | 1,319 | 521 | $10.31 | $14K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,204 | 23 | $0.23 | $273 |
| 80053 Clinical Chemistry | Office | 1,096 | 662 | $10.23 | $11K |
| 85652 Clinical Chemistry | Office | 949 | 539 | $2.61 | $2,481 |
| 86140 Clinical Chemistry | Office | 947 | 538 | $5.01 | $4,745 |
By year: 2022 $3.1M for 201,207 services; 2023 $3.1M for 200,779 services; 2024 $3.0M for 183,639 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,942 | 952 | $8.54 | $17K |
| 80053 Clinical Chemistry | 1,096 | 662 | $10.23 | $11K |
| 85652 Clinical Chemistry | 949 | 539 | $2.61 | $2,481 |
| 86140 Clinical Chemistry | 947 | 538 | $5.01 | $4,745 |
| 85027 Blood Count | 840 | 529 | $6.25 | $5,253 |
| 82306 Clinical Chemistry | 402 | 343 | $28.83 | $12K |
| 81003 Clinical Chemistry | 335 | 236 | $2.14 | $717 |
| 82570 Clinical Chemistry | 288 | 188 | $4.96 | $1,428 |
| 82550 Clinical Chemistry | 273 | 165 | $6.20 | $1,692 |
| 84443 Clinical Chemistry | 267 | 208 | $16.22 | $4,331 |
Medicare prescription drug claims, 2024
In 2024, the drug William C Tidmore Jr. prescribed most often to Medicare patients was Duloxetine Hcl, with 543 prescriptions and refills. In total William C Tidmore Jr. wrote 11,257 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 543 | 767 | 145 | $7,451 |
| Prednisone Generic | 528 | 671 | 184 | $3,224 |
| Hydroxychloroquine Sulfate Generic | 444 | 768 | 136 | $14K |
| Gabapentin Generic | 406 | 543 | 93 | $5,492 |
| Celecoxib Generic | 397 | 493 | 117 | $5,705 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 381 | 381 | 67 | $6,630 |
| Methotrexate Methotrexate Sodium | 379 | 604 | 99 | $5,757 |
| Tramadol Hcl Generic | 347 | 357 | 102 | $2,561 |
| Allopurinol Generic | 312 | 437 | 53 | $2,897 |
| Levothyroxine Sodium Generic | 270 | 399 | 40 | $2,043 |
| Humira(Cf) Pen Adalimumab | 222 | 226 | 34 | $1.7M |
| Atorvastatin Calcium Generic | 181 | 403 | 43 | $1,643 |
| Pregabalin Generic | 176 | 211 | 47 | $2,007 |
| Rosuvastatin Calcium Generic | 173 | 339 | 36 | $2,161 |
| Amlodipine Besylate Generic | 167 | 323 | 38 | $730 |
Brand drugs: 1,765 claims; generic drugs: 9,457 claims; opioid claims: 835.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William C Tidmore Jr. $781 ($781 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $121.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 6 | $121 |
| Genzyme Corporation SNY | 3 | $77.73 |
| Abbvie Inc. ABBV | 4 | $76.87 |
| Pfizer Inc. PFE | 4 | $76.82 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $54.89 |
| Dexcom, Inc. DXCM | 2 | $50.15 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.06 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $43.03 |
| UCB, Inc. UCB.BR | 2 | $41.55 |
| Novo Nordisk Inc NVO | 2 | $39.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.